Compound heterozygosity for a known and a novel defect in the lipoprotein lipase gene (Asp250->Asn; Ser251->Cys) resulting in lipoprotein lipase (LPL) deficiency

被引:13
作者
Bijvoet, SM
Wiebusch, H
Ma, Y
Reymer, PWA
Bruin, T
Bakker, HD
Funke, H
Assmann, G
Hayden, MR
Kastelein, JJP
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT VASC MED, NL-1105 AZ AMSTERDAM, NETHERLANDS
[2] UNIV MUNSTER, INST ARTERIOSKLEROSEFORSCH, D-4400 MUNSTER, GERMANY
[3] UNIV BRITISH COLUMBIA, DEPT MED GENET, VANCOUVER, BC V5Z 1M9, CANADA
[4] UNIV AMSTERDAM, CHILDRENS ACAD MED CTR, EMMA KINDERZIEKENHUIS, NL-1105 AZ AMSTERDAM, NETHERLANDS
基金
英国医学研究理事会;
关键词
lipoprotein lipase; mutation; chylomicronaemia;
D O I
10.1016/0300-2977(96)00043-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two missense mutations in exon 6 of the LPL gene were identified on separate alleles in a Dutch patient with lipoprotein lipase (LPL) deficiency. The first mutation is a G(1003) --> A transition resulting in a D250N mutation, which has been shown previously to result in a catalytically defective protein in patients of French-Canadian ancestry. The second mutation, a C to G transition at nucleotide 1007, predicts a S251C residue change in the highly conserved region of LPL surrounding the loop structure that covers the catalytic triad. This mutation constitutes a novel defect among LPL gene mutations reported so far. Site-directed mutagenesis experiments provide in-vitro evidence for the complete loss of LPL activity resulting from this latter missense mutation. The G(1003) --> A nucleotide substitution underlying the Asp(250) mutation deletes a TaqI endonuclease recognition site and the C-1007 --> G change that leads to the S251C alteration abolishes a HinfI recognition site. This will facilitate rapid screening for these mutations in LPL-deficient patients.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 35 条
  • [21] A MISSENSE MUTATION (ASP(250)-]ASN) IN EXON-6 OF THE HUMAN LIPOPROTEIN-LIPASE GENE CAUSES CHYLOMICRONEMIA IN PATIENTS OF DIFFERENT ANCESTRIES
    MA, YH
    WILSON, BI
    BIJVOET, S
    HENDERSON, HE
    CRAMB, E
    ROEDERER, G
    MURTHY, MRV
    JULIEN, P
    BAKKER, HD
    KASTELEIN, JJP
    BRUNZELL, JD
    HAYDEN, MR
    [J]. GENOMICS, 1992, 13 (03) : 649 - 653
  • [22] MA YH, 1992, J BIOL CHEM, V267, P1918
  • [23] A MISSENSE MUTATION AT CODON-188 OF THE HUMAN LIPOPROTEIN-LIPASE GENE IS A FREQUENT CAUSE OF LIPOPROTEIN-LIPASE DEFICIENCY IN PERSONS OF DIFFERENT ANCESTRIES
    MONSALVE, MV
    HENDERSON, H
    ROEDERER, G
    JULIEN, P
    DEEB, S
    KASTELEIN, JJP
    PERITZ, L
    DEVLIN, R
    BRUIN, T
    MURTHY, MRV
    CAGNE, C
    DAVIGNON, J
    LUPIEN, PJ
    BRUNZELL, JD
    HAYDEN, MR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) : 728 - 734
  • [24] MULDER M, 1993, J BIOL CHEM, V268, P9369
  • [25] OLIVECRONA T, 1985, J BIOL CHEM, V260, P6888
  • [26] Olivecrona T., 1987, LIPOPROTEIN LIPASE, P15
  • [27] STUDIES ON INACTIVATION OF LIPOPROTEIN-LIPASE - ROLE OF THE DIMER TO MONOMER DISSOCIATION
    OSBORNE, JC
    BENGTSSONOLIVECRONA, G
    LEE, NS
    OLIVECRONA, T
    [J]. BIOCHEMISTRY, 1985, 24 (20) : 5606 - 5611
  • [28] VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626
  • [29] WARNICK GR, 1978, J LIPID RES, V19, P65
  • [30] INFORMATIVENESS OF HUMAN (DC-DA)N.(DG-DT)N POLYMORPHISMS
    WEBER, JL
    [J]. GENOMICS, 1990, 7 (04) : 524 - 530